Peers warned that charging VAT on medicines donated through compassionate use and early-access schemes could reduce access for patients with rare cancers and other serious conditions; the Government said the tax treatment is long-standing, promised to work with HMRC, companies and charities on a quick patient-focused solution, but gave no figures on patients affected or revenue expected.